Paper12940901
Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis.
Ronco C and 10 others. Artif Organs, 2003. Cited by 244 papers, by iCite.
Cite this record
ConductScience Library. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Papers, record 12940901. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12940901
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytokines | Major topic |
| Renal Replacement Therapy | Major topic |
| Sepsis | Major topic |
| Acute Kidney Injury | |
| Critical Illness | |
| Humans | |
| Multiple Organ Failure |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00912184 | Study Comparing High Cut-off Haemofiltration With Standard Haemofiltration in Acute Renal Failure | Background | ClinicalTrials.gov | |
| NCT03456180 | Changes in Microvascular Perfusion During Blood Purification With Cytosorb® in Septic Shock | Background | ClinicalTrials.gov |
Cited by107
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 244 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941541 | oXiris-Based Blood Purification Efficacy in Adults with Septic Shock and Acute Kidney Injury: The PURE Multicenter Pilot Randomized Clinical Trial. | J Clin Med | 2026 | https://conductscience.org/library/papers/42941541 | PubMed |
| 42866125 | The effects of hemoadsorption in patients with sepsis-associated persistent severe AKI who require CRRT: A prospective, randomized controlled pilot study. | Ann Intensive Care | 2026 | https://conductscience.org/library/papers/42866125 | PubMed |
| 42396239 | Clinical applications of oXiris membranes: Targeting inflammation and renal dysfunction in ICU patients. | J Intensive Med | 2026 | https://conductscience.org/library/papers/42396239 | PubMed |
| 42288929 | The role of hemoadsorption in septic shock: toward a personalized approach. | Crit Care | 2026 | https://conductscience.org/library/papers/42288929 | PubMed |
| 41736101 | The international, prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: results from the first 300 patients. | J Anesth Analg Crit Care | 2026 | https://conductscience.org/library/papers/41736101 | PubMed |
| 41535952 | Multidisciplinary guidelines on renal replacement therapy in intensive care medicine. | Crit Care | 2026 | https://conductscience.org/library/papers/41535952 | PubMed |
| 41521316 | The "cytokine storm" in infection and sepsis: win the battle but lose the war. | Mil Med Res | 2026 | https://conductscience.org/library/papers/41521316 | PubMed |
| 41180104 | The international, prospective CytOSorbⓇ treatMent Of critically ill patientS (COSMOS) registry: Interim results from the first 150 patients. | J Intensive Med | 2025 | https://conductscience.org/library/papers/41180104 | PubMed |
| 40549176 | [S3 guideline on renal replacement therapy in intensive care medicine : Evidence-based implementation of renal replacement therapy in critically ill patients]. | Med Klin Intensivmed Notfmed | 2025 | https://conductscience.org/library/papers/40549176 | PubMed |
| 40382202 | Comparative efficacy of two hemopurification filters for treating intra-abdominal sepsis: A retrospective study. | Chin J Traumatol | 2025 | https://conductscience.org/library/papers/40382202 | PubMed |
| 40364014 | Immunomodulation in Pediatric Sepsis: A Narrative Review. | J Clin Med | 2025 | https://conductscience.org/library/papers/40364014 | PubMed |
| 40117010 | Haemoadsorption to remove inflammatory mediators in sepsis: past, present, and future. | Intensive Care Med Exp | 2025 | https://conductscience.org/library/papers/40117010 | PubMed |
| 39722012 | Use of extracorporeal blood purification therapies in sepsis: the current paradigm, available evidence, and future perspectives. | Crit Care | 2024 | https://conductscience.org/library/papers/39722012 | PubMed |
| 39708149 | Hemadsorption with CytoSorb®: focus on the latest experiences in cardiac surgery patients. | J Artif Organs | 2025 | https://conductscience.org/library/papers/39708149 | PubMed |
| 39500494 | The COSMOS Registry of CytoSorb Hemoadsorption Therapy in Critically Ill Patients: Protocol for an International, Prospective Registry. | JMIR Res Protoc | 2024 | https://conductscience.org/library/papers/39500494 | PubMed |
| 39411302 | Polymyxin B Hemoperfusion in Sepsis: A Possible Silver Lining to the Dark Clouds? | Indian J Crit Care Med | 2024 | https://conductscience.org/library/papers/39411302 | PubMed |
| 39200055 | Association between Extended Meropenem Regimen and Achievement of Aggressive PK/PD in Patients Receiving Continuous Renal Replacement Therapy for Septic AKI. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39200055 | PubMed |
| 39077704 | Comparative Effectiveness of Combined IgM-Enriched Immunoglobulin and Extracorporeal Blood Purification Plus Standard Care Versus Standard Care for Sepsis and Septic Shock after Cardiac Surgery. | Rev Cardiovasc Med | 2022 | https://conductscience.org/library/papers/39077704 | PubMed |
| 38890397 | Preclinical and first-in-human safety studies on a novel magnetism-based haemofiltration method. | Sci Rep | 2024 | https://conductscience.org/library/papers/38890397 | PubMed |
| 38633308 | Prevention and treatment strategies for kidney transplant recipients in the context of long-term existence of COVID-19. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/38633308 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CXCL8 | 3576 | PubTator's text mining | https://conductscience.org/library/genes/3576 | NCBI Gene |
| IL10 | 3586 | PubTator's text mining | https://conductscience.org/library/genes/3586 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12940901
GET https://conductscience.org/api/papers/v1/12940901/cited_by?page=2